
Company Info
Phone(617) 621-8097
Year Established
2007
Ticker
NVU
Exchange
NYSE
Contacts
Douglas M. Fambrough III, Ph.D.CEO
Company Description
Dicerna, a Novo Nordisk company, is a biopharmaceutical company focused on the discovery and development of innovative treatments for rare diseases, chronic liver diseases, cardiovascular disease, and viral liver infectious diseases.